Shizuoka, Japan

Setsuya Sasho

This inventor holds 1 USPTO granted patent. Top assignee: University of Pennsylvania. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Setsuya Sasho. Retrieved from https://idiyas.com/inventor/setsuya-sasho-46uydp5i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Setsuya Sasho

Introduction

Setsuya Sasho is a notable inventor based in Shizuoka-Ken, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of compositions that target ribonucleotide reductase enzymes. His work has implications for treating various diseases, including cancer and infections.

Latest Patents

Setsuya Sasho holds 1 patent related to peptides, peptide analogs, peptidomimetics, and other small molecules. His invention focuses on compositions that inhibit ribonucleotide reductase enzymes, which are crucial for DNA synthesis. The compositions include linear peptides, cyclic peptides, peptide analogs, and peptidomimetics. The methods outlined in his patent provide potential treatments for cancer and viral and bacterial infections.

Career Highlights

Setsuya Sasho is affiliated with the University of Pennsylvania, where he continues to advance research in his field. His academic background and ongoing research contribute to the understanding of enzyme inhibition and its therapeutic applications.

Collaborations

Some of his notable coworkers include Barry S Cooperman and Ralph F Hirschmann. Their collaborative efforts enhance the research environment and foster innovation in biochemistry.

Conclusion

Setsuya Sasho's work exemplifies the intersection of innovation and practical application in the medical field. His contributions to peptide research hold promise for future therapeutic developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…